144. Lennox-Gastaut syndrome Clinical trials / Disease details

Clinical trials : 101 / Drugs : 68 - (DrugBank : 12) / Drug target genes : 49 - Drug target pathways : 60

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04133480 (ClinicalTrials.gov)	October 2020	17/10/2019	Investigation of Cognitive Outcomes With Cannabidiol Oral Solution	An Open-Label Exploratory Investigation of Cognitive Outcomes With Cannabidiol Oral Solution (EPIDIOLEX®; GWP42003-P)	Lennox-Gastaut Syndrome	Drug: GWP42003-P	GW Research Ltd	NULL	Withdrawn	3 Years	10 Years	All	0	Phase 4	United States
2	NCT02318537 (ClinicalTrials.gov)	December 30, 2017	12/12/2014	Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome	A Multicenter, Randomized, Double-blind, Placebo-controlled, Interventional Study to Assess the Safety and Efficacy of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut Syndrome	Lennox-Gastaut Syndrome	Drug: Cannabidiol Oral Solution;Drug: Placebo Solution	INSYS Therapeutics Inc	NULL	Withdrawn	2 Years	30 Years	All	0	Phase 3	NULL